Report Detail

Request for Sample of this report

Other Global Endogenous Peptide Substances Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4564041
    • |
  • 07 November, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Endogenous Peptide Substances market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The driving force of endogenous peptides mainly comes from the following aspects:
Biological functions of bioactive peptides: Bioactive peptides have a variety of biological functions, such as neuromodulation, immune regulation, anti-inflammation, anti-tumor, etc. These functions play an important role in maintaining normal physiological functions and health of the human body. For example, endorphins have analgesic effects and can relieve pain, while growth hormone-releasing hormone can stimulate the secretion of growth hormone and regulate the growth and development of the human body. These functions enable endogenous peptides to play important physiological roles in the human body.
Demand for drug research and development: With the development of medical technology, people's demand for drugs is getting higher and higher. As an important type of biological drugs, peptide drugs are receiving more and more attention in their research and development and application. Peptide drugs have many advantages, such as high efficiency, low toxicity, and good biocompatibility. Therefore, they are widely used in anti-tumor, anti-infection, neurological diseases and other fields. As an important source of peptide drugs, endogenous peptides have received more attention in their development and utilization.
Progress in production technology: Since the chemical structure and biological activity of endogenous peptides are strictly protected, special attention needs to be paid to maintaining their original biological activity during production and processing. With the continuous advancement of production technology, people have explored more efficient and safer preparation methods, which has greatly improved the production efficiency of endogenous peptides and reduced costs.
Expansion of indications: As the research and development of endogenous peptides continues to deepen, their indications are also expanding. For example, insulin is an important drug in the treatment of diabetes, while growth hormone is widely used in anti-aging and other fields. The expansion of these indications has led to an increasing demand for endogenous peptides.
The Global Info Research report includes an overview of the development of the Endogenous Peptide Substances industry chain, the market status of Research (Neuropeptides, Hormones), Medicine (Neuropeptides, Hormones), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Endogenous Peptide Substances.
Regionally, the report analyzes the Endogenous Peptide Substances markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Endogenous Peptide Substances market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Endogenous Peptide Substances market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Endogenous Peptide Substances industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Neuropeptides, Hormones).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Endogenous Peptide Substances market.
Regional Analysis: The report involves examining the Endogenous Peptide Substances market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Endogenous Peptide Substances market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Endogenous Peptide Substances:
Company Analysis: Report covers individual Endogenous Peptide Substances players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Endogenous Peptide Substances This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research, Medicine).
Technology Analysis: Report covers specific technologies relevant to Endogenous Peptide Substances. It assesses the current state, advancements, and potential future developments in Endogenous Peptide Substances areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Endogenous Peptide Substances market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Endogenous Peptide Substances market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Neuropeptides
Hormones
Cytokines
Peptide Hormones
Bioactive Peptides
Market segment by Application
Research
Medicine
Others
Market segment by players, this report covers
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Biosynth Carbosynth
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Peptide Institute
Abbexa
Phoenix Pharmaceuticals
Creative Peptides
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Endogenous Peptide Substances product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Endogenous Peptide Substances, with revenue, gross margin and global market share of Endogenous Peptide Substances from 2018 to 2023.
Chapter 3, the Endogenous Peptide Substances competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Endogenous Peptide Substances market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Endogenous Peptide Substances.
Chapter 13, to describe Endogenous Peptide Substances research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Endogenous Peptide Substances
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Endogenous Peptide Substances by Type
    • 1.3.1 Overview: Global Endogenous Peptide Substances Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Endogenous Peptide Substances Consumption Value Market Share by Type in 2022
    • 1.3.3 Neuropeptides
    • 1.3.4 Hormones
    • 1.3.5 Cytokines
    • 1.3.6 Peptide Hormones
    • 1.3.7 Bioactive Peptides
  • 1.4 Global Endogenous Peptide Substances Market by Application
    • 1.4.1 Overview: Global Endogenous Peptide Substances Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medicine
    • 1.4.4 Others
  • 1.5 Global Endogenous Peptide Substances Market Size & Forecast
  • 1.6 Global Endogenous Peptide Substances Market Size and Forecast by Region
    • 1.6.1 Global Endogenous Peptide Substances Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Endogenous Peptide Substances Market Size by Region, (2018-2029)
    • 1.6.3 North America Endogenous Peptide Substances Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Endogenous Peptide Substances Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Endogenous Peptide Substances Market Size and Prospect (2018-2029)
    • 1.6.6 South America Endogenous Peptide Substances Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Endogenous Peptide Substances Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Assertio Therapeutics Inc.
    • 2.1.1 Assertio Therapeutics Inc. Details
    • 2.1.2 Assertio Therapeutics Inc. Major Business
    • 2.1.3 Assertio Therapeutics Inc. Endogenous Peptide Substances Product and Solutions
    • 2.1.4 Assertio Therapeutics Inc. Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Assertio Therapeutics Inc. Recent Developments and Future Plans
  • 2.2 Cipher Pharmaceuticals Inc.
    • 2.2.1 Cipher Pharmaceuticals Inc. Details
    • 2.2.2 Cipher Pharmaceuticals Inc. Major Business
    • 2.2.3 Cipher Pharmaceuticals Inc. Endogenous Peptide Substances Product and Solutions
    • 2.2.4 Cipher Pharmaceuticals Inc. Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Cipher Pharmaceuticals Inc. Recent Developments and Future Plans
  • 2.3 Endo International Plc
    • 2.3.1 Endo International Plc Details
    • 2.3.2 Endo International Plc Major Business
    • 2.3.3 Endo International Plc Endogenous Peptide Substances Product and Solutions
    • 2.3.4 Endo International Plc Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Endo International Plc Recent Developments and Future Plans
  • 2.4 Biosynth Carbosynth
    • 2.4.1 Biosynth Carbosynth Details
    • 2.4.2 Biosynth Carbosynth Major Business
    • 2.4.3 Biosynth Carbosynth Endogenous Peptide Substances Product and Solutions
    • 2.4.4 Biosynth Carbosynth Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Biosynth Carbosynth Recent Developments and Future Plans
  • 2.5 Lannett Co. Inc.
    • 2.5.1 Lannett Co. Inc. Details
    • 2.5.2 Lannett Co. Inc. Major Business
    • 2.5.3 Lannett Co. Inc. Endogenous Peptide Substances Product and Solutions
    • 2.5.4 Lannett Co. Inc. Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Lannett Co. Inc. Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Endogenous Peptide Substances Product and Solutions
    • 2.6.4 Pfizer Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Johnson & Johnson
    • 2.7.1 Johnson & Johnson Details
    • 2.7.2 Johnson & Johnson Major Business
    • 2.7.3 Johnson & Johnson Endogenous Peptide Substances Product and Solutions
    • 2.7.4 Johnson & Johnson Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.8 Peptide Institute
    • 2.8.1 Peptide Institute Details
    • 2.8.2 Peptide Institute Major Business
    • 2.8.3 Peptide Institute Endogenous Peptide Substances Product and Solutions
    • 2.8.4 Peptide Institute Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Peptide Institute Recent Developments and Future Plans
  • 2.9 Abbexa
    • 2.9.1 Abbexa Details
    • 2.9.2 Abbexa Major Business
    • 2.9.3 Abbexa Endogenous Peptide Substances Product and Solutions
    • 2.9.4 Abbexa Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Abbexa Recent Developments and Future Plans
  • 2.10 Phoenix Pharmaceuticals
    • 2.10.1 Phoenix Pharmaceuticals Details
    • 2.10.2 Phoenix Pharmaceuticals Major Business
    • 2.10.3 Phoenix Pharmaceuticals Endogenous Peptide Substances Product and Solutions
    • 2.10.4 Phoenix Pharmaceuticals Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Phoenix Pharmaceuticals Recent Developments and Future Plans
  • 2.11 Creative Peptides
    • 2.11.1 Creative Peptides Details
    • 2.11.2 Creative Peptides Major Business
    • 2.11.3 Creative Peptides Endogenous Peptide Substances Product and Solutions
    • 2.11.4 Creative Peptides Endogenous Peptide Substances Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Creative Peptides Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Endogenous Peptide Substances Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Endogenous Peptide Substances by Company Revenue
    • 3.2.2 Top 3 Endogenous Peptide Substances Players Market Share in 2022
    • 3.2.3 Top 6 Endogenous Peptide Substances Players Market Share in 2022
  • 3.3 Endogenous Peptide Substances Market: Overall Company Footprint Analysis
    • 3.3.1 Endogenous Peptide Substances Market: Region Footprint
    • 3.3.2 Endogenous Peptide Substances Market: Company Product Type Footprint
    • 3.3.3 Endogenous Peptide Substances Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Endogenous Peptide Substances Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Endogenous Peptide Substances Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Endogenous Peptide Substances Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Endogenous Peptide Substances Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Endogenous Peptide Substances Consumption Value by Type (2018-2029)
  • 6.2 North America Endogenous Peptide Substances Consumption Value by Application (2018-2029)
  • 6.3 North America Endogenous Peptide Substances Market Size by Country
    • 6.3.1 North America Endogenous Peptide Substances Consumption Value by Country (2018-2029)
    • 6.3.2 United States Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Endogenous Peptide Substances Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Endogenous Peptide Substances Consumption Value by Type (2018-2029)
  • 7.2 Europe Endogenous Peptide Substances Consumption Value by Application (2018-2029)
  • 7.3 Europe Endogenous Peptide Substances Market Size by Country
    • 7.3.1 Europe Endogenous Peptide Substances Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 7.3.3 France Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Endogenous Peptide Substances Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Endogenous Peptide Substances Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Endogenous Peptide Substances Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Endogenous Peptide Substances Market Size by Region
    • 8.3.1 Asia-Pacific Endogenous Peptide Substances Consumption Value by Region (2018-2029)
    • 8.3.2 China Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 8.3.5 India Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Endogenous Peptide Substances Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Endogenous Peptide Substances Consumption Value by Type (2018-2029)
  • 9.2 South America Endogenous Peptide Substances Consumption Value by Application (2018-2029)
  • 9.3 South America Endogenous Peptide Substances Market Size by Country
    • 9.3.1 South America Endogenous Peptide Substances Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Endogenous Peptide Substances Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Endogenous Peptide Substances Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Endogenous Peptide Substances Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Endogenous Peptide Substances Market Size by Country
    • 10.3.1 Middle East & Africa Endogenous Peptide Substances Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Endogenous Peptide Substances Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Endogenous Peptide Substances Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Endogenous Peptide Substances Market Drivers
  • 11.2 Endogenous Peptide Substances Market Restraints
  • 11.3 Endogenous Peptide Substances Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Endogenous Peptide Substances Industry Chain
  • 12.2 Endogenous Peptide Substances Upstream Analysis
  • 12.3 Endogenous Peptide Substances Midstream Analysis
  • 12.4 Endogenous Peptide Substances Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Endogenous Peptide Substances. Industry analysis & Market Report on Endogenous Peptide Substances is a syndicated market report, published as Global Endogenous Peptide Substances Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Endogenous Peptide Substances market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,766.60
    		4,149.90
    		5,533.20
    		3,219.00
    		4,828.50
    		6,438.00
    		544,341.60
    		816,512.40
    		1,088,683.20
    		290,684.40
    		436,026.60
    		581,368.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo